![Leonard van den Berg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Leonard van den Berg
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
QurAlis Corp.
![]() QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA.
16
| Holding Company | Pharmaceuticals: Major | 16 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Leonard van den Berg via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Muna Therapeutics ApS
![]() Muna Therapeutics ApS Medical/Nursing ServicesHealth Services Muna Therapeutics ApS is a Danish private biopharmaceutical company that discovers and develops therapies to slow or stop neurodegenerative diseases such as Alzheimer's, frontotemporal dementia, and Parkinson's. Muna Therapeutics is based in Copenhagen, DK and was founded in 2020 by Simon Glerup and Bart de Strooper. The company focuses on identifying new medicines to preserve cognition and other brain functions and enhance resilience to these diseases. Rita Balice-Gordon has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
Enclear Therapies, Inc.
![]() Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA. | Pharmaceuticals: Major | Founder Founder | |
Therini Bio, Inc.
![]() Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Puretech Health LLC
![]() Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
Rice University | College/University | Undergraduate Degree | |
UDG HEALTHCARE PLC | Miscellaneous Commercial Services | Director/Board Member | |
MADRIGAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
SALIX PHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Chairman | |
Aerami Therapeutics, Inc.
![]() Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chairman | |
Sanofi US Services, Inc.
![]() Sanofi US Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi US Services, Inc. engages in the research, production and distribution of pharmaceutical products. The company is based in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
Anne Whitaker Group LLC | Corporate Officer/Principal | ||
Aerami Therapeutics Holdings, Inc.
![]() Aerami Therapeutics Holdings, Inc. Medical SpecialtiesHealth Technology Dance Biopharm Holdings, Inc. engages in providing health care services. The company was founded by John Stuart Patton in 2010 and is headquartered in San Francisco, CA. | Medical Specialties | Chief Executive Officer | |
VECTURA GROUP | Pharmaceuticals: Major | Director/Board Member | |
MALLINCKRODT PLC | Pharmaceuticals: Major | Director/Board Member | |
Novoclem Therapeutics
![]() Novoclem Therapeutics Pharmaceuticals: MajorHealth Technology Novoclem Therapeutics develops inhalable treatments for antibiotic-resistant pathogens found in patients with cystic fibrosis and other respiratory diseases. The private company is based in Durham. | Pharmaceuticals: Major | Chief Executive Officer | |
KNOW Bio LLC
![]() KNOW Bio LLC Pharmaceuticals: MajorHealth Technology KNOW Bio LLC engages in the development and optimization of a nitric oxide platform providing therapies that focuses on curing diseases and conditions. The company was founded in 2015 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chief Executive Officer | |
BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Chairman | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
FARON PHARMACEUTICALS OY | Pharmaceuticals: Major | Director/Board Member | |
GlaxoSmithKline LLC
![]() GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Delta Communications, Inc.
![]() Delta Communications, Inc. Specialty TelecommunicationsCommunications Delta Communications, Inc. supplies data communications products and systems. The company was founded in 1973 and headquartered in Waukesha, WI. | Specialty Telecommunications | Corporate Officer/Principal | |
WOLFSPEED, INC. | Semiconductors | Director/Board Member | |
National Pharmaceutical Council
![]() National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
University of North Alabama | College/University | Director/Board Member | |
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
Nocion Therapeutics, Inc.
![]() Nocion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nocion Therapeutics, Inc. is a biopharmaceutical company, which targets neurons mediating cough, itch, pain and inflammation without the addictive properties of opioids. The company was founded by Bruce Bean, Clifford Woolf and Bruce David Levy and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder | |
Sanofi Ventures
![]() Sanofi Ventures Investment ManagersFinance Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
OxThera AB
![]() OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
Cambridge Judge Business School | College/University | Masters Business Admin | |
University of Barcelona | College/University | Doctorate Degree | |
Minoryx Therapeutics SL
![]() Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
Inbiomotion SL
![]() Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain. | Medical Specialties | Director/Board Member | |
Bryn Pharma LLC
![]() Bryn Pharma LLC Medical SpecialtiesHealth Technology Bryn Pharma LLC engages in the provision of emergency allergy drug cabinets. The company was founded in 2017 and is headquartered in Beverly Hills, CA. | Medical Specialties | Director/Board Member | |
Mahzi Therapeutics, Inc.
![]() Mahzi Therapeutics, Inc. BiotechnologyHealth Technology Mahzi Therapeutics is a private biotechnology company that focuses on genetic therapies for rare genetic neurodevelopmental disorders. The company was founded by Yael Weiss and is based in San Mateo, CA. The company unites patient and family groups, academic researchers, diagnostic companies, other industry members, and its internal team of experts to develop therapies for patients with these serious diseases. Mahzi's team is experienced in all aspects of biopharmaceutical research, development, and manufacturing and is driven to make a difference in the lives of patients with rare genetic diseases. Yael Weiss has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Allero Therapeutics BV
![]() Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Allero Therapeutics BV is a biopharmaceutical company, which engages in the development of immunotherapies. It focuses on the research and development pipeline with a focus on a celiac disease product and a food allergy product. The company was founded by Poul Sorensen, Emil Pot, Federico Grego, and Kees Leenhouts and is headquartered in Rotterdam, the Netherlands. | Miscellaneous Commercial Services | Chairman | |
Xenocor, Inc.
![]() Xenocor, Inc. Medical SpecialtiesHealth Technology Xenocor, Inc. is a privately held corporation based in Utah that offers a suite of leading-edge, fog-free, disposable surgical technologies for minimally invasive, abdominal, and thoracic procedures. The American company also offers a suite of leading-edge, fog-free, single-use endoscopes for minimally invasive surgical procedures. These products emerged from the Center for Medical Innovation and are FDA cleared, CE marked, and patent protected. The company was founded by John Langell, Lane Brooks, and Sourav Kole, and the CEO is Evan Kelso. | Medical Specialties | Founder | |
Reservoir Neuroscience, Inc.
![]() Reservoir Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Reservoir Neuroscience, Inc. develops novel therapeutics. It focuses on treating dysfunctional blood vessels in the brain other neurological disorders. The company was founded by Aaron Friedman in 2019 and is headquartered in Berkeley, CA. | Pharmaceuticals: Major | Director/Board Member | |
Mindimmune Therapeutics, Inc.
![]() Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mindimmune Therapeutics, Inc. develops drugs that target the immune system to treat diseases of the central nervous system. It focuses on the treatment of Alzheimer's, Huntington's disease, pain, and psychiatric disorders. The company was founded by Stevin Zorn, Frank S. Menniti, Robert B. Nelson, and Brian M. Campbell on July 12, 2016 and is headquartered in Kingston, RI. | Pharmaceuticals: Major | Director/Board Member | |
Cerevance, Inc.
![]() Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | Medical Specialties | Director/Board Member | |
Libra Therapeutics, Inc.
![]() Libra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Libra Therapeutics, Inc. operates as biotechnology company which develops novel disease-modifying therapeutics. It focuses on the areas of amyotrophic lateral sclerosis, frontotemporal dementia, Alzheimer's, Parkinson's, and Huntington's disease. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
NeuroTherapia, Inc.
![]() NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology NeuroTherapia, Inc. discovers and develops new therapies for diseases with an underlying component of neuroinflammation. The company was founded by Mohamed Naguib Attala and Joseph F. Foss in 2015 and is headquartered in Cleveland, OH. | Pharmaceuticals: Major | Director/Board Member | |
Dolby Family Ventures LLC
![]() Dolby Family Ventures LLC Investment ManagersFinance Dolby Family Ventures (Dolby) is a venture capital firm founded in 2013. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Paros Bio, Inc.
![]() Paros Bio, Inc. BiotechnologyHealth Technology Paros Bio, Inc. is a private company that specializes in gene therapy for neurodegenerative diseases. The company is based in Boston, MA. The company is focused on developing a gene replacement approach to treat autosomal dominant Alzheimer's disease (ADAD). Specifically, they are working on a gene therapy that targets mutations in the presenilin 1 gene (PSEN1), which is the underlying genetic cause of ADAD. | Biotechnology | Director/Board Member | |
Sairopa B V
![]() Sairopa B V MiscellaneousMiscellaneous Sairopa B V is a Dutch company that develops medicines and operates as an investment holding company. | Miscellaneous | Director/Board Member | |
Vrije Universiteit Amsterdam | College/University | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 35 |
Verenigd Koninkrijk | 4 |
Spanje | 4 |
Nederland | 4 |
Ierland | 3 |
Sectoraal
Health Technology | 33 |
Consumer Services | 6 |
Finance | 5 |
Commercial Services | 5 |
Health Services | 2 |
Operationeel
Director/Board Member | 89 |
Corporate Officer/Principal | 25 |
Private Equity Investor | 14 |
Founder | 14 |
Chief Executive Officer | 13 |
Sterkste connecties
Insiders | |
---|---|
Anne Michelle Whitaker | 35 |
Roel Bulthuis | 29 |
Luc Dochez | 26 |
Sourav Kole | 11 |
Laia Crespo | 10 |
Johannes Nielsen | 9 |
Cillian King | 9 |
Jonathan Behr | 8 |
Kevin Eggan | 8 |
Clifford J. Woolf | 6 |
Kasper Roet | 2 |
Ammar Al-Chalabi | 1 |
Dame Shaw | 1 |
Philip Van Damme | 1 |
Amy Schulman | 1 |
- Beurs
- Insiders
- Leonard van den Berg
- Bedrijfsconnecties